Thrombosis research
Developing a decision support tool for the continuation or deprescribing of antithrombotic therapy in patients receiving end-of-life care: Results of a European Delphi study.
DELPHI Serenity Group, Isabelle Mahé, Skerdi Haviari, Nassima Si Mohammed, Anette Arbjerg Højen, Carme Font, Stavros Konstantinides, Marieke J H A Kruip, Luigi Maiorana, Sebastian Szmit, Denise Abbel, Laurent Bertoletti, Adrian Edwards, Michelle Edwards, Alessandra Gava
Published: 202610.1016/j.thromres.2025.109573
Abstract
INTRODUCTION: To develop a European shared decision-support tool (SDST), a two-round Delphi process was used to achieve consensus on aspects relating to the antithrombotic therapy (ATT) deprescribing discussions and process in end-of-life cancer pati…
Preview only. Read the full abstract at the source